Louks Ronald Allen 4
4 · NantHealth, Inc. · Filed Sep 14, 2021
Insider Transaction Report
Form 4
Louks Ronald Allen
Chief Operating Officer
Transactions
- Sale
Common Stock
2021-09-13$1.96/sh−9,200$18,039→ 225,857 total - Exercise/Conversion
Stock Option (right to buy)
2021-09-10−7,320→ 519,862 totalExercise: $0.55Exp: 2029-08-12→ Common Stock (7,320 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-09-13−9,200→ 510,662 totalExercise: $0.55Exp: 2029-08-12→ Common Stock (9,200 underlying) - Exercise/Conversion
Common Stock
2021-09-10$0.55/sh+7,320$4,027→ 233,177 total - Sale
Common Stock
2021-09-10$2.05/sh−7,320$15,042→ 225,857 total - Exercise/Conversion
Common Stock
2021-09-13$0.55/sh+9,200$5,061→ 235,057 total
Footnotes (3)
- [F1]Represents the weighted average share price of an aggregate total of 7,320 shares sold in the price range of $1.98 to $2.29 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 9,200 shares sold in the price range of $1.96 to $1.97 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Subject to the reporting person continuing as a service provider, the shares subject to the option shall vest as follows, fifty percent (50%) of the shares subject to the option shall vest on the one (1) year anniversary from the date of grant, and twenty-five percent (25%) of the remaining shares subject to the option shall vest annually thereafter, so that the option is fully vested on the three (3) year anniversary date.